FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Similar survival seen with simple versus radical hysterectomy for cervical cancer

2.

Despite Medicare Coverage, Cancer Genomic Testing Still Low

3.

A Surgical First for Removal of an Appendiceal Neoplasm

4.

Long-Acting Interferon Therapy Approved for ET

5.

fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot